Abstracts tagged "Early Rheumatoid Arthritis and glucocorticoids"

Abstract Number: 389 • 2014 ACR/ARHP Annual Meeting
High 11B-HSD1 Activity Is Associated with Progression to Rheumatoid Arthritis in Patients with a New Onset of Inflammatory Arthritis
Dominika Nanus¹, Andrew Filer², Lorraine Yeo¹, Dagmar Scheel-Toellner³, Rowan Hardy⁴, Gareth Lavery⁵, Paul Stewart⁶, Christopher Buckley⁷, Mark Cooper⁸ and Karim Raza¹, ¹Rheumatology Research Group, University of Birmingham, Birmingham, United Kingdom, ²Rheumatology Research Group, MRC Centre for Immune Regulation, School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom, ³Rheumatology Research Group, Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK, Birmingham, United Kingdom, ⁴Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, United Kingdom, ⁵Centre for Endocrinology, Diabetes and Metabolism,, University of Birmingham, Birmingham, United Kingdom, ⁶University of Leeds, Leeds, United Kingdom, ⁷Rheumathology Research Group, University of Birmingham, Birmingham, United Kingdom, ⁸University of Sydney, ANZAC Research Institute, Sydney, Australia
Background/Purpose Inadequate endogenous glucocorticoid (GC) synthesis during inflammation has been proposed as an aetiological factor in the development of rheumatoid arthritis (RA). It has been…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].